Sintomatología obsesivo-compulsiva como precursora de un trastorno neurocognitivo

  1. Jorge López Álvarez
  2. Sara Solera Mena
  3. Irina Alina Bogza
  4. Luis F. Agüera Ortiz
Psiquiatría biológica: Publicación oficial de la Sociedad Española de Psiquiatría Biológica

ISSN: 1134-5934

Year of publication: 2018

Volume: 25

Issue: 2

Pages: 84-86

Type: Article


More publications in: Psiquiatría biológica: Publicación oficial de la Sociedad Española de Psiquiatría Biológica


Cited by

  • Scopus Cited by: 0 (28-01-2024)
  • Dimensions Cited by: 0 (20-12-2023)

SCImago Journal Rank

  • Year 2018
  • SJR Journal Impact: 0.103
  • Best Quartile: Q4
  • Area: Psychiatry and Mental Health Quartile: Q4 Rank in area: 530/595

Índice Dialnet de Revistas

  • Year 2018
  • Journal Impact: 0.030
  • Field: PSICOLOGÍA Quartile: C4 Rank in field: 79/116

Scopus CiteScore

  • Year 2018
  • CiteScore of the Journal : 0.1
  • Area: Psychiatry and Mental Health Percentile: 4


(Data updated as of 20-12-2023)
  • Total citations: 0
  • Recent citations (2 years): 0
  • Field Citation Ratio (FCR): 0.0


Objective: to demonstrate how the use of the International Society to Advance Alzheimer's Research and Treatment (ISTAART) criteria for mild behavioural impairment (MBI) and also how the MBI-C Checklist can facilitate the early diagnosis of neurocognitive disorders. Clinical case: a 63 year-old patient, with an obsessive-compulsive disorder of 5 years onset. The negative progression, in spite of a correct treatment, led to the suspicion of a neurodegenerative process, regardless of a non-pathological cognitive screening and functional integrity. On further neuropsychological examination the clinical suspicion was confirmed. The use of the ISTAART criteria and the MBI-C Checklist is shown in order to clarify how its use can help to orientate a correct diagnosis. Results: an extensive neuropsychological examination confirmed the diagnosis of a neurocognitive disorder in this patient, and corroborates the usefulness of the MBI concept. Conclusions: the use of the MBI and MBI-C Checklist facilitates the diagnosis of neurocognitive disorders in their earlier stages, despite the apparent absence of cognitive or functional impairment.